Brensocatib 10 mg
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Insmed Incorporated
Overview
Brensocatib 10 mg is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Brensocatib 10 mg clinical trials
Explore related
Medical disclaimer. This page summarizes research about Brensocatib 10 mg for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.